Skip to content

Labcorp Holdings LH Diagnostics — Goodwill acquired, excluding measurement period adjustments

Other segment segments

Biopharma Laboratory Services
$0

Similar metrics at other companies

Revvity logo
RVTYDiagnostics — Goodwill
$1.86B-4.0%
Opko Health logo
OPKDiagnostics — Goodwill
$163.44M0.0%
Opko Health logo
OPKDiagnostics — Goodwill Impaired Accumulated Impairment Loss
$17.98M0.0%
Bio-Rad Laboratories logo
BIOClinical Diagnostics — Goodwill, net
$128.4M+4.3%
Bio-Rad Laboratories logo
BIOClinical Diagnostics — Goodwill, Period Increase (Decrease)
$0-100%
Danaher logo
DHRDiagnostics — Goodwill
$6.96B+1.8%

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's diagnostics — goodwill acquired, excluding measurement period adjustments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's diagnostics — goodwill acquired, excluding measurement period adjustments?
Labcorp Holdings (LH) reported diagnostics — goodwill acquired, excluding measurement period adjustments of $146.6M in Q1 2026.
What is the long-term trend for Labcorp Holdings's diagnostics — goodwill acquired, excluding measurement period adjustments?
Over 3 years (2021 to 2024), Labcorp Holdings's diagnostics — goodwill acquired, excluding measurement period adjustments has grown at a 16.8% compound annual growth rate (CAGR), from $245.1M to $390.5M.
What does diagnostics — goodwill acquired, excluding measurement period adjustments mean?
This metric tracks the gross amount of goodwill recognized specifically from new acquisitions completed during the reporting period, excluding subsequent adjustments made during the measurement period. It isolates the capital deployed for inorganic growth within the diagnostics segment.